Today’s AI Top Pick: PSIX
10/1/2026 · Highly Shorted Deep Rotation RSI & Conf screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live PSIX price forecast →
PSIX is the only name in the pool that achieves clean multi-timeframe agreement while sitting at a low position in its range. On the 4h it is at 46.08 with fc_short_pct of 80.14 and fc_long_pct of 75.12 (both strongly positive), sitting 89.1% of the way through its 21-bar range but only -2.99% off the high — the forecast cone is pointing up across all three horizons. The 1d shows fc_long_pct of 32.93 with pos_in_21bar_range_pct of 91.06 and just -2.17% drawdown, and the 1wk fc_long_pct of -44.65 reflects a longer-cycle base rather than a breakdown. Bullish probability is 1.0 and near_term_bullish is 1.0, meaning the model sees both immediate and sustained upside. Fundamentally it is the strongest candidate in the pool: P/E 15.63, forward P/E just 11.78, ROE 40.07%, sales YoY +13.17%, operating margin 13%, and a 51.8% analyst target upside, with a recommendation of 1 (strong buy). Short float of 21% provides the squeeze fuel the screen is built around. Critically, the news flow is a clean tailwind: on 2026-09-30 the company secured a $220M committed revolving credit facility — no dilution, no guidance cut, no short-seller report, just balance-sheet capacity to fund growth. This is the ideal convergence: strong fundamentals, positive forecast tape, low drawdown, and a catalyst that reinforces rather than undercuts the thesis. Today is the right entry because the 4h/1d forecast cones are elevated but not extended, the credit facility removes funding risk, and waiting risks a short-squeeze move given 21% short interest against a 40% ROE business trading at a forward P/E under 12. The entry is justified by the fact that PSIX is not chasing — despite being 89% through its 21-bar range intraday, the drawdown is minimal (-2.99% on 4h) and the multi-timeframe forecast is uniformly positive, so the pullback-to-buy logic is satisfied by the forecast cone rather than waiting for a lower price that may not come given the bullish probability of 1.0.

- Short float of 21% cuts both ways — a failed squeeze could accelerate downside on low volume
- perfYear of -53.2% shows a broken longer-term trend that could reassert if macro weakens
- perfYtd of -19.55% indicates the stock is still in a downtrend and could gap lower on market stress
- peg of 2.01 suggests the forward earnings growth is already priced in, limiting multiple expansion
- instOwn of only 35.07% means lower institutional coverage and higher volatility risk
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | PSIX | BUY NOW | 14.3 | Clean multi-timeframe bullish agreement, 40% ROE, forward P/E under 12, 21% short float, and a $220M credit facility catalyst — the ideal convergence. |
| 2 | GRRR | BUY PULLBACK | 8.8 | Strong AI catalysts and 19% short float but near_term_bullish is 0 and the 4h drawdown of -33% warns against chasing. |
| 3 | SMMT | BUY PULLBACK | 8.3 | $2B AstraZeneca investment is a huge catalyst but no fundamentals and mixed multi-timeframe forecast limit conviction. |
| 4 | CRML | BUY PULLBACK | 8.3 | 31% short float and critical minerals narrative but no fundamentals and a -27.67% 4h drawdown with fc_long_pct of 45.02. |
| 5 | SERV | BUY PULLBACK | 8.0 | near_term_bullish of 1.0 and 31% short float are compelling but negative margins and a -43.94% 1wk forecast cap the setup. |
| 6 | BLSH | WAIT | 8.0 | Bullish but KBW cut its target to $40 and near_term_bullish is null, so wait for a clearer technical read. |
| 7 | XPOF | BUY PULLBACK | 7.8 | 30% short float and 78% gross margin are attractive but guidance cuts and a UBS target cut to $4.5 are a landmine. |
| 8 | BTBT | BUY PULLBACK | 7.5 | near_term_bullish of 0.8 and 18% short float but crypto exposure and negative margins add volatility risk. |
| 9 | TGTX | WAIT | 7.5 | Strong BRIUMVI growth and 21% short float but expected_return is -40% and near_term_bullish is 0, so wait. |
| 10 | EBS | BUY PULLBACK | 7.0 | near_term_bullish of 0.8 and a Buy rating but the Naloxone breakdown headline is a partial landmine. |
| 11 | SEI | WAIT | 6.5 | Positive earnings and 27% short float but near_term_bullish is 0 and the $1B notes issue adds leverage risk. |
| 12 | PRGO | WAIT | 6.3 | Defensive pharma with 16% short float but negative margins and a -14.78% fc_long_pct on 1d limit the setup. |
| 13 | GEMI | WAIT | 6.0 | Gemini crypto exposure and 27% short float but near_term_bullish is null and the setup is unclear. |
| 14 | ARQT | BUY PULLBACK | 5.8 | 16% short float and Simone Biles catalyst are nice but a 127x P/E and near_term_bullish of 0.4 warrant caution. |
| 15 | ARQQ | WAIT | 5.6 | 41% short float is the highest in the pool but P/S of 384 and near_term_bullish of 0.2 make it a speculative hold. |
| 16 | TDC | BUY PULLBACK | 5.5 | Cheap at 6x P/E with 17% short float but a COO dumping $1.4M and near_term_bullish of 0.4 are red flags. |
| 17 | AMKR | WAIT | 5.5 | Semiconductor tailwind and 16% short float but near_term_bullish is 0 and the 4h drawdown of -34.6% warns off chasers. |
| 18 | UPXI | WAIT | 5.4 | Overweight from Cantor at $2 target but near_term_bullish is 0 and negative margins limit conviction. |
| 19 | OMER | WAIT | 5.3 | Overweight upgrade and transplant drug upside but a CAO sell and near_term_bullish of 0 make it a wait. |
| 20 | BIRD | BUY PULLBACK | 5.3 | $450M funding and 206% target upside are compelling but near_term_bullish of 0.2 and -32% 1wk forecast cap the setup. |
| 21 | CDZI | BUY PULLBACK | 5.1 | 17% short float and dividend support but debt/equity of 25.69 and negative margins are serious cautions. |
| 22 | GO | WAIT | 5.0 | B of A upgrade to Buy is positive but negative margins and near_term_bullish of 0 limit the setup. |
| 23 | RXRX | WAIT | 5.0 | 37% short float and AI-drug narrative are attractive but near_term_bullish of 0.4 and negative margins warrant a wait. |
| 24 | SIG | WAIT | 4.8 | Value at 11x P/E with 16% short float but near_term_bullish of 0 and a -3.24% 4h drawdown suggest patience. |
| 25 | STAA | BUY PULLBACK | 4.7 | Stifel upgrade and China growth catalyst with 15% short float but a 340x P/E is stretched. |
| 26 | CEPT | WAIT | 4.5 | 48% short float is the highest but near_term_bullish is null and the data is stale (as of Jul 18). |
| 27 | INO | BUY PULLBACK | 9.5 | PDUFA date on Oct 30 is a binary catalyst with 19% short float but near_term_bullish of 0.6 and -100% sales YoY add risk. |
| 28 | KULR | BUY PULLBACK | 9.8 | 15% short float and cash runway but a SeekingAlpha cash burn headline and near_term_bullish of 0.2 limit conviction. |
| 29 | TSSI | BUY PULLBACK | 11.8 | Margin improvement narrative and 18% short float but sales YoY of -26.52% and near_term_bullish of 0.4 cap the setup. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord